
Journal of Medicinal Chemistry p. 1174 - 1181 (1984)
Update date:2022-08-04
Topics:
Wissner
Sum
Schaub
Kohler
Goldstein
Analogues of platelet activating factor (PAF) in which the ether oxygen has been removed and in which the alkoxy chain at C1 has been replaced with a o-, p-, or m-alkylphenoxy group (30, 31, and 35, respectively) have been prepared. Compound 6 shows reduced platelet aggregation and hypotensive activity in comparison with C16 and C18 PAF. The results obtained for compounds 30, 31, and 35 indicate that the hypotensive and platelet aggregating responses are sensitive to structural modification of the ether chain. The ortho analogue 30 shows no platelet aggregating activity and only a weak hypotensive response. The para analogue 31 exhibits a moderate decrease in activity in both assays. The meta analogue 35 is the most active of the three.
View MoreHunan Haili Chemical Industry Co.,Ltd.
Contact:+86-731-85521860
Address:No.251, 2nd Section, Furong Road, Changsha,Hunan,China
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
zhejiang huangyan wanfeng pharm chem co.ltd
Contact:+86-576- 84160728
Address:No. 5 Dazha Road, Economic,Development Zone(JiangKou), Zhejiang, China
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
Jinan Jiaquan Chemical Co.,Ltd
Contact:+86-531-62318366
Address:Room 502 of Yidonghuayuan No.601 Huaxin Road Licheng District Jinan China
Doi:10.1016/j.jcat.2021.02.030
(2021)Doi:10.1055/s-2006-942452
(2006)Doi:10.1016/j.tetlet.2008.04.132
(2008)Doi:10.1016/j.bmc.2006.10.012
(2007)Doi:10.1246/cl.2006.712
(2006)Doi:10.1021/jo01058a059
(1962)